NYSE:CTSTCannTrust Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CannTrust Holdings Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.64 0.00 (0.00 %) (As of 04/14/2020) Add Compare Share Today's RangeC$0.64Now: C$0.64▼C$0.6450-Day RangeC$0.64MA: C$0.64▼C$0.6452-Week RangeC$0.38Now: C$0.64▼C$8.17VolumeN/AAverage VolumeN/AMarket CapitalizationC$90.27 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsEarningsInsider TradesInstitutional OwnershipHeadlinesOptions ChainShort InterestSocial Media CannTrust Holdings Inc. produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.Read More Beat the Market (BTM) Rank™ 3.0 Analyst's Opinion Consensus RatingCannTrust has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of C$2.00, CannTrust has a potential upside of 213.5% from its current price of C$0.64.Amount of Analyst CoverageCannTrust has received no research coverage in the past 90 days. Previous Next 2.4 Community Rank Outperform VotesCannTrust has received 174 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCannTrust has received 193 “underperform” votes. (Add your “underperform” vote.)Community SentimentCannTrust has received 52.59% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote “Outperform” if you believe CTST will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CTST will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCannTrust does not currently pay a dividend.Dividend GrowthCannTrust does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CannTrust insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 0.04% of the stock of CannTrust is held by institutions. Previous Next 0.6 Earnings and Valuation Price to Book Value per Share RatioCannTrust has a P/B Ratio of 0.50. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.21 out of 5 stars Industry, Sector and Symbol Stock Exchange NYSE Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolNYSE:CTST Previous Symbol CUSIPN/A CIKN/A Webwww.canntrust.ca Phone64-7872-2300Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$35.22 million Price / Sales2.56 Cash FlowN/A Price / Cash FlowN/A Book ValueC$1.27 per share Price / Book0.50Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees576 Outstanding Shares141,490,000Market CapC$90.27 million Next Earnings DateN/A OptionableOptionable Receive CTST News and Ratings via Email Sign-up to receive the latest news and ratings for CTST and its competitors with MarketBeat's FREE daily newsletter. CannTrust (NYSE:CTST) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of CannTrust? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for CannTrust. What price target have analysts set for CTST? 1 equities research analysts have issued twelve-month price targets for CannTrust's stock. Their forecasts range from C$2.00 to C$2.00. On average, they anticipate CannTrust's share price to reach C$2.00 in the next twelve months. This suggests a possible upside of 213.5% from the stock's current price. View analysts' price targets for CannTrust. Has CannTrust been receiving favorable news coverage? News headlines about CTST stock have been trending somewhat positive on Saturday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. CannTrust earned a media sentiment score of 0.6 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news about CannTrust. Are investors shorting CannTrust? CannTrust saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 12,910,000 shares, an increase of 12.6% from the December 31st total of 11,470,000 shares. Based on an average daily trading volume, of 1,770,000 shares, the short-interest ratio is presently 7.3 days. Currently, 10.8% of the shares of the company are sold short. View CannTrust's Short Interest. Who are some of CannTrust's key competitors? Some companies that are related to CannTrust include Passage Bio (IMRA), Progenics Pharmaceuticals (PGNX), Magenta Therapeutics (MGTA), Catalyst Pharmaceuticals (CPRX), Neptune Wellness Solutions (NEPT), Wave Life Sciences (WVE), Calithera Biosciences (CALA), Beyondspring (BYSI), CytomX Therapeutics (CTMX), Geron (GERN), REDHILL BIOPHAR/S (RDHL), Pivot Pharmaceuticals (PVOTF), Aeglea Bio Therapeutics (AGLE), MEI Pharma (MEIP) and Immunic (IMUX). View all competitors. What other stocks do shareholders of CannTrust own? Based on aggregate information from My MarketBeat watchlists, some companies that other CannTrust investors own include Aurora Cannabis (ACB), Canopy Growth (CGC), Aphria (APHA), KushCo (KSHB), Cronos Group (CRON), Aurora Cannabis (ACB), OrganiGram (OGI), HEXO (HEXO), Nokia Oyj (NOK) and Aphria (APHA). Who are CannTrust's key executives? CannTrust's management team includes the following people: Mr. Eric Paul, Co-Founder & Chairman (Age 78)Mr. Brad Rogers, Pres (Age 49)Mr. Ian Abramowitz, Sr. VP of Global Investments & Partnerships (Age 64)Mr. Peter Ralph Aceto, Chief Exec. OfficerMr. Greg Guyatt, Chief Financial Officer What is CannTrust's stock symbol? CannTrust trades on the New York Stock Exchange (NYSE) under the ticker symbol "CTST." What is CannTrust's stock price today? One share of CTST stock can currently be purchased for approximately C$0.64. How big of a company is CannTrust? CannTrust has a market capitalization of C$90.27 million and generates C$35.22 million in revenue each year. CannTrust employs 576 workers across the globe. What is CannTrust's official website? The official website for CannTrust is www.canntrust.ca. How can I contact CannTrust? CannTrust's mailing address is 3280 LANGSTAFF ROAD UNIT 1, VAUGHAN A6, L4K 4Z8. The company can be reached via phone at 64-7872-2300 or via email at [email protected] This page was last updated on 8/15/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
